BRPI1009843A2 - composição farmacêutica e método para previnir ou tratar doenças relacionadas com o estilo de vida, uso de um açúcar, e, produto alimentício. - Google Patents

composição farmacêutica e método para previnir ou tratar doenças relacionadas com o estilo de vida, uso de um açúcar, e, produto alimentício.

Info

Publication number
BRPI1009843A2
BRPI1009843A2 BRPI1009843A BRPI1009843A BRPI1009843A2 BR PI1009843 A2 BRPI1009843 A2 BR PI1009843A2 BR PI1009843 A BRPI1009843 A BR PI1009843A BR PI1009843 A BRPI1009843 A BR PI1009843A BR PI1009843 A2 BRPI1009843 A2 BR PI1009843A2
Authority
BR
Brazil
Prior art keywords
foodstuff
sugar
preventing
pharmaceutical composition
treating lifestyle
Prior art date
Application number
BRPI1009843A
Other languages
English (en)
Inventor
Ichiro Asano
Kazuto Ozaki
Naoto Imura
Shigeyoshi Fujii
Toshio Kumaoh
Original Assignee
Ajinomoto General Foods Inc
Kraft Foods Global Brands Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto General Foods Inc, Kraft Foods Global Brands Llc filed Critical Ajinomoto General Foods Inc
Publication of BRPI1009843A2 publication Critical patent/BRPI1009843A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI1009843A 2009-03-26 2010-03-24 composição farmacêutica e método para previnir ou tratar doenças relacionadas com o estilo de vida, uso de um açúcar, e, produto alimentício. BRPI1009843A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2009/056115 WO2010109626A1 (ja) 2009-03-26 2009-03-26 生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
PCT/JP2010/055078 WO2010110313A1 (ja) 2009-03-26 2010-03-24 生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品

Publications (1)

Publication Number Publication Date
BRPI1009843A2 true BRPI1009843A2 (pt) 2016-03-15

Family

ID=42780335

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009843A BRPI1009843A2 (pt) 2009-03-26 2010-03-24 composição farmacêutica e método para previnir ou tratar doenças relacionadas com o estilo de vida, uso de um açúcar, e, produto alimentício.

Country Status (6)

Country Link
US (1) US9101648B2 (pt)
EP (1) EP2412375A4 (pt)
KR (1) KR101723529B1 (pt)
CN (1) CN102448468B (pt)
BR (1) BRPI1009843A2 (pt)
WO (2) WO2010109626A1 (pt)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH635485A5 (de) 1978-08-22 1983-04-15 Coffex Ag Verfahren zum entcoffeinieren von rohkaffee.
JPS62111671A (ja) 1985-11-11 1987-05-22 Ajinomoto General Foods Kk 生コ−ヒ−豆からの食品用天然抗酸化剤の製造方法
CA1324287C (en) 1988-09-14 1993-11-16 Howard Dave Stahl Process for hydrolyzing a partially extracted roasted and ground coffee
JP3477628B2 (ja) 1995-06-19 2003-12-10 アサヒビール株式会社 ホップ苞より得られるポリフェノール製剤とその製造法
JPH09143465A (ja) 1995-11-21 1997-06-03 Dainippon Ink & Chem Inc 抗酸化性組成物
JP3855293B2 (ja) 1996-02-14 2006-12-06 長谷川香料株式会社 酸化防止剤組成物
US6576275B1 (en) 1999-02-02 2003-06-10 Archer-Daniels-Midland Company Process for extracting polyphenolic antioxidants from purine-containing plants
DE19961182B4 (de) 1999-12-18 2006-01-12 Südzucker AG Mannheim/Ochsenfurt Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung
JP4179741B2 (ja) 2000-09-22 2008-11-12 アサヒ飲料株式会社 リンゴポリフェノールを含有する飲料
JP2002262827A (ja) * 2001-03-13 2002-09-17 Ajinomoto General Foods Inc マンノオリゴ糖を含有する血清脂質改善組成物
JP3691453B2 (ja) 2002-04-30 2005-09-07 アサヒ飲料株式会社 コーヒー飲料及びその製造方法
JP2004267177A (ja) 2003-03-04 2004-09-30 Servicetec Japan Corp 液体中のポリフェノールの除去方法
JP4113829B2 (ja) 2003-10-24 2008-07-09 株式会社 伊藤園 グルタミン酸含有食品素材及びその製造方法
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
JP2006042624A (ja) 2004-08-02 2006-02-16 Ajinomoto General Foods Inc クロロゲン酸含有飲料
JP4488852B2 (ja) * 2004-09-17 2010-06-23 味の素ゼネラルフーヅ株式会社 体内脂肪低減作用を有する組成物
JP4960591B2 (ja) * 2004-12-14 2012-06-27 味の素ゼネラルフーヅ株式会社 マンノオリゴ糖類を含有する抗アレルゲン組成物
JP2006193502A (ja) 2004-12-17 2006-07-27 Asahi Breweries Ltd アディポネクチン調節剤、それを含有する飲食品、食品添加物及び医薬
WO2006064761A1 (ja) 2004-12-17 2006-06-22 Asahi Breweries, Ltd. アディポネクチン調節剤、それを含有する飲食品、食品添加物及び医薬
US8029829B2 (en) 2005-02-03 2011-10-04 Taiyo Kagaku Co., Ltd. Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy
JP4955928B2 (ja) 2005-03-01 2012-06-20 花王株式会社 クロロゲン酸類組成物の製造方法
JP2006306799A (ja) 2005-04-28 2006-11-09 Kao Corp クロロゲン酸類組成物の製造方法
US20060286238A1 (en) 2005-06-20 2006-12-21 The Procter & Gamble Company Processes for isolating bitter quinides for use in food and beverage products
JP4673753B2 (ja) 2006-01-16 2011-04-20 味の素ゼネラルフーヅ株式会社 マンノオリゴ糖を含有する血清脂質改善剤
EP1980258A4 (en) * 2006-01-24 2010-03-10 Ajinomoto General Foods Inc COMPOSITION FOR IMPACTING BLOOD PRESSURE AND / OR PREVENTING BLOOD PRESSURE INCAPATION AND FOOD OR BEVERAGE CONTAINING THEREOF
JP5021223B2 (ja) 2006-03-16 2012-09-05 ユニチカ株式会社 アディポネクチン分泌促進剤、インスリン抵抗性改善剤及び抗動脈硬化剤
JP4851215B2 (ja) * 2006-03-27 2012-01-11 味の素ゼネラルフーヅ株式会社 マンノオリゴ糖を含有するミネラル吸収促進組成物
JP4771882B2 (ja) 2006-07-21 2011-09-14 味の素ゼネラルフーヅ株式会社 糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
CN101808653B (zh) 2007-09-26 2014-03-05 高砂香料工业株式会社 植物提取物及其用途
JP5054499B2 (ja) 2007-12-10 2012-10-24 花王株式会社 脂質代謝改善剤
JP4667514B2 (ja) 2009-05-07 2011-04-13 味の素ゼネラルフーヅ株式会社 クロロゲン酸含有飲料

Also Published As

Publication number Publication date
WO2010110313A1 (ja) 2010-09-30
EP2412375A1 (en) 2012-02-01
KR20120008036A (ko) 2012-01-25
CN102448468A (zh) 2012-05-09
CN102448468B (zh) 2014-12-03
US9101648B2 (en) 2015-08-11
KR101723529B1 (ko) 2017-04-05
EP2412375A4 (en) 2012-09-26
WO2010109626A1 (ja) 2010-09-30
US20120101058A1 (en) 2012-04-26

Similar Documents

Publication Publication Date Title
BRPI1013984A2 (pt) composto , composição farmacêutica, método para tratamento ou profilaxia de uma doença ou condição, e, uso de um composto.
BR112013013435A2 (pt) composto, composição farmacêutica, uso de um composto, método para a profilaxia ou tratamento de um estado ou condição de doença mediados por uma cinase de fgfr, e, processo para a preparação de um composto.
BRPI0913585A2 (pt) composto, método para fabricar um composto, composição farmacêutica, uso de um composto, e, método para o tratamento ou prevenção de distúrbios
BR112012018947A8 (pt) composição farmacêutica para o tratamento e/ou prevenção de um câncer, anticorpo, combinação farmacêutica e método para o tratamento e/ou prevenção de um câncer
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI1005153A2 (pt) composto, composição farmacêutica, uso de um composto, metodo para tratar um indivíduo que sofre de uma condição patológica ou doença e produto de combinação
BR112012004333A2 (pt) composto, composição farmacêutica, e, método para o tratamento ou a prevenção de uma doença ou um distúrbio.
BR112012018951A2 (pt) composição farmacêutica, combinação farmacêutica e método para o tratamento e\ou prevenção de um câncer e anticorpo
BRPI1008383A2 (pt) composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
BRPI0917458A2 (pt) composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto
BR112015003397A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente.
BRPI0816881A2 (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para tratar doenças ou distúrbios e para preparar um composto.
BRPI0815591A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
BR112015006019A2 (pt) composto selecionado, composição farmacêutica, método para tratar uma doença ou distúrbio, uso de um composto, kit para tratar uma condição mediada por pim quinase e invenção.
BRPI1013396A2 (pt) composto, produto farmacêutico de combinação, uso de um composto, método para tratar uma doença ou condição, e, processo para a preparação de um composto.
BR112014010206A2 (pt) composto, composição farmacêutica, uso de composto, e, método para a profilaxia ou tratamento de um estado ou condição de doença
BRPI0810246A2 (pt) Inibidores da dpp-iv incluindo o grupo beta-amino, método de preparação do mesmo e composição farmacêutica contendo o mesmo para prevenção e tratamento da diabetes ou obesidade.
BR112012000422A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para a prevenir tratar ou melhorar doenças do sistema imune
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BRPI1013559A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada à função trpa1 e respectivos usos
BR112014011671A2 (pt) composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto
BRPI0907977A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BR112014032510A2 (pt) composto, composição farmacêutica, método para tratar ou prevenir uma doença ou desordem, e, uso de um composto.
BRPI0915382A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou um distúrbio.
BRPI0816175A2 (pt) Composições adequadas para tratamento de doença, distúrbio ou condição da espinha.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: AJINOMOTO GENERAL FOODS, INC. (JP) , INTERCONTINEN

B25G Requested change of headquarter approved

Owner name: AJINOMOTO GENERAL FOODS, INC. (JP) , INTERCONTINEN

B25A Requested transfer of rights approved

Owner name: AJINOMOTO GENERAL FOODS, INC. (JP) , KONINKLIJKE D

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/715 (2006.01), A23L 29/30 (2016.01), A23L

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2507 DE 22-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.